Pages

▼
Wednesday, December 18, 2024

Drug Channels News Roundup, December 2024: Crazy Medicare Reimbursements, Independents Grow (Really!), AFP Risks, Pharmacy History, GLP-1 Jokes, and Two Cool Dudes

›
Happy New Year, everyone! It’s been a huge year for Drug Channels Institute (DCI). In January, HMP Global acquired DCI . Thanks to our new ...
Friday, December 13, 2024

Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts (rerun)

›
This week, I’m rerunning some popular posts while I prepare for today’s Drug Channels Outlook 2025 live video webinar. (If you sign up bef...
Thursday, December 12, 2024

White Bagging Update 2024: Providers’ Pushback Preserves Buy-and-Bill (rerun)

›
This week, I’m rerunning some popular posts while I prepare for tomorrow’s Drug Channels Outlook 2025 live video webinar. During the webin...
Wednesday, December 11, 2024

Follow the 340B Prescription Dollar: How PBMs Profit from 340B Contract Pharmacies (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s Drug Channels Outlook 2025 live video webinar. During the webinar...
Tuesday, December 10, 2024

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s Drug Channels Outlook 2025 live video webinar. Click here to see ...
Monday, December 09, 2024

Humira Biosimilar Price War Update: Should We Be Glad that CVS Health and Express Scripts Are Using Private Label Products to Pop the Gross-to-Net Bubble? (rerun)

›
This week, I’m rerunning some popular posts while I prepare for Friday’s Drug Channels Outlook 2025 live video webinar. Click here to see ...
Tuesday, December 03, 2024

Four Revelations from Minnesota’s First 340B Transparency Report

›
It’s time to pay attention to the money behind the 340B curtain. Minnesota just released the industry‘s first ever mandated financial repor...
Monday, November 25, 2024

Drug Channels News Roundup, November 2024: Employers & Their PBMs, Medicaid vs. 340B, U.S. Drug Prices, and Dr. G Shops for Health Plans

›
Happy Thanksgiving, everyone! Before you stretch your stomach, stretch your mind with our extra-stuffed helping of food for thought. In this...
Friday, November 22, 2024

Addressing Gaps in Access: Strategies to Optimize Your Prescription Journey

›
Today’s guest post comes from Catherine Wood Hill, SVP of Marketing at PHIL. Catherine reviews the prescription lifecycle from the perspe...
Tuesday, November 19, 2024

Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market

›
In Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market , I documented the Inflation Reduction Act’s (IRA) d...
Friday, November 15, 2024

From Integration to AI: The Data-Driven Future of Market Access

›
Today’s guest post comes from Kala Bala, SVP, Enterprise Access & Data Expertise, MMIT, a Norstella company and Dinesh Kabaleeswaran, ...
Wednesday, November 13, 2024

Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market

›
Uh oh. As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. For 2025, DCI’s exclusive analysi...